Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 9 Months Postpartum.
Dyspareunia
About this trial
This is an interventional treatment trial for Dyspareunia focused on measuring dyspareunia, radiofrequency, postpartum pain, perineal massage, episiotomy
Eligibility Criteria
Inclusion Criteria:
- 4-9 postpartum
- de novo dyspareunia after delivery
- obstetric injury
- Grant informed consent
Exclusion Criteria:
- radiofrequency contraindications (pacemaker, active infection or pregnancy)
- cesarean section
- dyspareunia previous to labour
- previous vulvo-vaginal pathology
- patients with postpartum depression
- patients with a pelvic region oncological history
Sites / Locations
- Hospital Clinic BarcelonaRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
ON Radiofrequency treatment
Sham Radiofrequency treatment
Application of the technique in the intervention group (activated resistive capacitive monopolar radiofrequency therapy): the intervention group will receive treatment with activated RF, with the electrode at a medium intensity for 20 minutes per session during a total of 5 sessions, the 3 first ones held weekly and the 2 last ones every other week.
Application of the technique in the intervention group (inactive resistive capacitive monopolar radiofrequency therapy): the intervention group will receive treatment with inactive RF, with the electrode at a medium intensity for 20 minutes per session during a total of 5 sessions, the 3 first ones held weekly and the 2 last ones every other week.